This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Varian Medical's CEO Presents At Bank Of America Merrill Lynch Healthcare Conference Call (Transcript)

Varian Medical Systems, Inc. (VAR)

Bank of America Merrill Lynch Health Care Conference Call

May 15, 2012 04:00 pm ET

Executives

Elisha W. Finney – Corporate Executive Vice President, Finance and Chief Financial Officer

Spencer R. Sias – Vice President, Corporate Communications and Investor Relations

Analysts



Presentation



Unidentified Analyst

[Call Starts Abruptly]

Analyst at B of A. And here with me from Varian, we have Elisha Finney, the CFO, and Spencer Sias, the Head of Investor Relations. Elisha's is going to go ahead and speak for 15 minutes or so, and then we will open it up for Q&A.

Elisha W. Finney

Thank you, [Lenux]. What we thought we would do is just give a brief summary this afternoon and then make sure we leave time to answer any questions that you might have. I will be making some forward-looking statements. Varian's mission is focusing energy on saving lives. And in all three of our business segments, we focus x-ray energy. In Oncology Systems, we focus our energy on tumors, so that we can kill cancer and kill patients. In the X-ray Products Division, we focus energy on better diagnosis, so that you can be diagnosed earlier.

And then finally, in our Security and Inspection Products business, we are focusing energy on inspecting cargo and having safer borders and ports. The mission or the goal of the company is to save an additional 100,000 life each and every year. We treat about over 2 million patients per year, and we are all at the company very dedicated to reaching this goal.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs